Some health plans are partnering with public health departments and statewide services to develop disaster plan to help avert the potential catastrophic effects of a flu pandemic. As an integrated delivery system, SelectHealth in Salt Lake City is working with the Utah Department of Health, which developed the Utah Pandemic Influenza Response, a preparedness plan in coordination with efforts by WHO and the U.S. Department of Health & Human Services. The state's primary goals are to minimize serious illness and deaths, societal disruption and economic loss.
Some health plans are partnering with public health departments and statewide services to develop disaster plan to help avert the potential catastrophic effects of a flu pandemic. As an integrated delivery system, SelectHealth in Salt Lake City is working with the Utah Department of Health, which developed the Utah Pandemic Influenza Response, a preparedness plan in coordination with efforts by WHO and the U.S. Department of Health & Human Services. The state's primary goals are to minimize serious illness and deaths, societal disruption and economic loss.
Kenneth Schaecher, MD, medical director for utilization management, says that SelectHealth is not worried about a possible flu pandemic but also does not want to wait too long to put a plan into place. "We want to ensure that we have the ability to perform operations and continue workflow, appropriately revise drug reimbursement of necessary drugs, make provisions for potential shortages of drugs and account for the needs of our members," he says. "We cannot afford to disrupt our services so we need to put an infrastructure in place to handle a disaster."
BlueCross BlueShield of Tennessee, serving 3 million members, is coordinating its efforts with the Tennessee Department of Health, which created action guidelines in 2003 with an emphasis on vaccination. The insurer is also taking advantage of preparedness efforts by the Blue Cross and Blue Shield Assn. "The federal government has learned lessons from [Hurricane] Katrina," says Inga Himelright, a regional medical director for the health plan headquartered in Chattanooga. "It takes individual and community preparation."
The disaster plan, which is currently being developed, will assess the impact of the pandemic on members, address the problems related to a substantially reduced workforce, educate the public, create policies to ensure that business operations continue and maintain relationships with the provider community.
Although cases of the avian flu have been reported since 1997, Dr. Himelright admits that plans have been slow to rise to the occasion but emphasizes the need to take action before fear takes over.
Positive Results for Ruxolitinib Cream in Children with Atopic Dermatitis Presented in Ongoing Study
March 18th 2024Ruxolitinib cream showed positive results in children 2- to 11-years-old with mild to moderate atopic dermatitis (AD), according to data of a poster presented at the American Academy of Dermatology Annual Meeting in San Diego from March 8 to 12.
Read More
FDA Updates for Week of March 11: First CAR-T for CLL/SLL and First NASH Treatment
March 16th 2024The FDA this week approved a few firsts: the first treatment for NASH and the first CAR-T cell therapy for CLL/SLL. Other approvals include Tevimbra for esophageal cancer; Livmarli for second liver disease indication; and Praluent for children with genetic form of high cholesterol. The FDA also issued a CRL for monthly MS drug. Additionally, Celltrion submitted an application for an interchangeable Xolair biosimilar.
Read More
A Deep Dive into Predictive and Generative AI with Lynn Carroll of HSBlox
January 3rd 2024In this month’s episode, Briana Contreras, an editor of MHE, chatted with Lynn Carroll, executive of HSBlox, about the difference between predictive and generative AI, yet how each works together in preventive healthcare.
Listen
Transforming the management of genetic testing
March 15th 2024This e-book will explain where the current genetic test management system is inadequate and how a new approach designed specifically for genetic testing will perform better and provide more meaningful and actionable results.
Read More